Advertisement

The genetic epidemiology of ovarian cancer

  • D. F. Easton
  • D. Ford
  • F. E. Matthews
  • J. Peto

Abstract

Anecdotal evidence for familial clustering of ovarian cancer dates back many years, ovarian tumours occurring in more than one member of the same family being reported as early as 1877 [1]. Since then a number of families containing multiple cases of ovarian cancer have been reported [2,3]. Many of these families also segregate early onset breast cancer [4] or other cancers [5] and the families have generally been suggestive of an autosomal dominant gene conferring a high lifetime risk of disease. Over the past few years more rapid progress has been made in understanding the possible inherited basis of ovarian cancer, firstly through population based epidemiological studies of familial risks and secondly through genetic linkage studies which have demonstrated that many breast-ovarian cancer families are the result of a predisposing gene on chromosome 17q known as BRCAl [6,7]. In this paper we review some of the epidemiological evidence on genetic susceptibility to ovarian cancer and the 17q linkage studies. We also consider the risks of ovarian cancer conferred by mutations in the BRCAl gene and examine the likely contribution of BRCAl to familial ovarian cancer and to ovarian cancer in general.

Keywords

Breast Cancer Ovarian Cancer Lynch Syndrome Ovarian Cancer Patient Male Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Olshausen (1877). Die Krankheiten der Ovarian, P. Enke, Stuttgart.Google Scholar
  2. 2.
    Liber, A.F. (1950) Ovarian cancer in mother and five daughters.Arch. Pathol., 49,280–90.Google Scholar
  3. 3.
    Fraumeni, J.F. Jr, Grundy, G.W., Creagan, E.T. and Eversen, R.B. (1975) Six families prone to ovarian cancer. Cancer, 36,364–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Lynch, H.T., Harris R.E., Guirgis, H.A. et al, (1978) Familial association of breast/ovarian cancer. Cancer, 41,1543–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Lynch, H.T., Albano, W.A., Lynch, J.F. et al, (1982) Surveillance and management of patients for high risk of ovarian carcinoma. Obstet. Gynecol.w, 59,59–96.PubMedGoogle Scholar
  6. 6.
    Hall, J.M., Lee, M.K., Morrow, J. et al, (1990) Linkage analysis of early onset familial breast cancer to chromosome 17q21.Science, 250, 1684–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Narod, S.A., Feuteun, J., Lynch, H.T. et al, (1991) Familial breast-ovarian cancer locus on chromosome 17ql2-q23. Lancet, 338, 82–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Casagrande, J.T., Pike, M.C., Ross, R.K. et al, (1979) Incessant ovulation’ and ovarian cancer risk. Lancet, ii, 170–3.Google Scholar
  9. 9.
    Hildreth, N.G., Kelsey, S.L., Li Volsi, V. et al, (1981) An epidemiologic study of epithelial carcinoma of the ovary. Am. J. Epidemiol., 114, 398–405.PubMedGoogle Scholar
  10. 10.
    Cramer, D.W., Hutchinson, G.B., Welch, W.R. et al, (1983) Determinants of ovarian cancer risk I: reproductive experiences and family history, J. Natl Cancer Inst., 71, 711–16.PubMedGoogle Scholar
  11. 11.
    Tzonou, A., Day, N.E., Trichopolous, D. et al, (1984) The epidemiology of ovarian cancer in Greece: a case-control study. Eur. J. Cancer Clin. Oncol., 20,1045–52.PubMedCrossRefGoogle Scholar
  12. 12.
    Booth, M.A. (1986) Aspects of the epidemiology of ovarian cancer. PhD Thesis, University of London.Google Scholar
  13. 13.
    Schildkraut, J.M. and Thompson, W.D. (1988) Familial ovarian cancer: a population based case-control study. Am. J. Epidemiol., 128, 456–66.PubMedGoogle Scholar
  14. 14.
    Koch, M., Gaedke, H. and Jenkins, H. (1989) Family history of ovarian cancer: a case-control study. Int. J. Epidemiol., 18, 782–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Easton, D.E. and Peto, J. (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surveys., 9,395–416.PubMedGoogle Scholar
  16. 16.
    Easton, D.F., Matthews, F., Swerdlow, A.J. and Peto, J. (1994) Cancer risks to relatives of ovarian cancer patients. Submitted.Google Scholar
  17. 17.
    Schildkraut, J.M., Risch, N. and Thompson, W.D. (1989) Evaluating genetic association among ovarian, breast and endometrial cancer: evidence for a breast ovarian relationship. Am. J. Hum. Genet., 45,521–9.PubMedGoogle Scholar
  18. 18.
    Cancer and Steroid Hormone Study (1987) The reduction in the risk of ovarian cancer associated with oral contraceptive use. N. Engl J. Med., 316, 650–5.CrossRefGoogle Scholar
  19. 19.
    Lynch, H.T., Kimberling, W., Albano, W.A. et al, (1985) Hereditary non polyposis colrectal cancer (Lynch syndrome I and syndrome II) 1. Clinical description of the resource. Cancer, 56, 934–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Peltomaki, P., Aaltonen, L.A., Sistonen, P. et al, (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science, 260, 810–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Peto, J., Easton, D.F., Matthews, F. and Swerdlow, A.J. (1994) Cancer risks to relatives of breast cancer patients. Submitted.Google Scholar
  22. 22.
    Easton, D.F., Bishop, D.T., Ford, D. et al, (1993) Genetic linkage analysis in familial breast and ovarian cancer — results from 214 famiUes. Am. J. Hum. Genet., 52,678–701.PubMedGoogle Scholar
  23. 23.
    Simard, J., Feunteun, J., Lenoir, G. et al, (1993) Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17ql2–21: exclusion of candidate genes EDH17B2 and RARA. Hum. Mol Genet., 2, 1193–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Goldgar, D.E., Rowe, K., Cannon-Albright, L. et al, (1994) Genetic epidemiology of famiUal ovarian cancer in Utah. In Ovarian Cancer 3, (eds F. Sharp, P. Mason, J. Berek, A.D. Blackett), Chapman & Hall, London.Google Scholar
  25. 25.
    Smith, S.A., Easton, D.F., Ford, D. et al, (1993) Genetic heterogeneity and localisation of a familial breast-ovarian cancer gene on chromosome 17ql2-q21. Am. J. Hum. Genet., 52, 767–76.PubMedGoogle Scholar
  26. 26.
    Feunteun, J., Narod, S.A., Lynch, H.T. et al, (1993) A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am. J. Hum. Genet., 52,736–42.PubMedGoogle Scholar
  27. Easton, D.F., Ford, D., Bishop, D.T. et al, The risks of breast and ovarian cancer in BRCAl gene carriers. In preparation.Google Scholar
  28. 28.
    Steichen-Gersdorf, E., Smith, S.A., Ponder, M.A. et al, (1994) Analysis of eight families with familial epithelial ovarian cancer for linkage to BRCAl on 17ql2–21; prospects for genetic diagnosis. Submitted.Google Scholar
  29. Ford, D., Peto, J., Easton, D.F. et al, Estimates of the gene frequency of BRCAl, and its contribution to breast and ovarian cancer incidence. In preparation.Google Scholar
  30. 30.
    Risch, N. (1987) Assessing the role of HLA- linked and unlinked determinants of disease. Am. J. Hum. Genet., 40,1–14.PubMedGoogle Scholar
  31. 31.
    Jacobs, I.J., Smith, S.A., Wiseman, R.W., et al, (1993) A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res., 53, 1218–21.PubMedGoogle Scholar
  32. 32.
    Smith, S.A., Easton, D.F., Evans, D.G.R. and Ponder, B.A.J. (1992) Allele losses in the region 17ql2-q21 in familial breast and ovarian cancer involve the wild type chromosome. Nature Genet., 2, 128–33.PubMedCrossRefGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • D. F. Easton
  • D. Ford
  • F. E. Matthews
  • J. Peto

There are no affiliations available

Personalised recommendations